{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:30:47Z","timestamp":1787909447397,"version":"build-2784847793"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100001032","name":"The Chicago Community Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01AI118257"],"award-info":[{"award-number":["R01AI118257"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U19AI135964"],"award-info":[{"award-number":["U19AI135964"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K24AI04831"],"award-info":[{"award-number":["K24AI04831"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21AI153953"],"award-info":[{"award-number":["R21AI153953"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["KL2TR002002"],"award-info":[{"award-number":["KL2TR002002"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Aminoglycoside-containing regimens may be an effective treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp), but aminoglycoside-resistance genes are common in these strains. The relationship between the aminoglycoside-resistance genes and aminoglycoside MICs remains poorly defined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To identify genotypic signatures capable of predicting aminoglycoside MICs for CR-Kp.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Clinical CR-Kp isolates (n\u2009=\u2009158) underwent WGS to detect aminoglycoside-resistance genes. MICs of amikacin, gentamicin, plazomicin and tobramycin were determined by broth microdilution (BMD). Principal component analysis was used to initially separate isolates based on genotype. Multiple linear regression was then used to generate models that predict aminoglycoside MICs based on the aminoglycoside-resistance genes. Last, the performance of the predictive models was tested against a validation cohort of 29 CR-Kp isolates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the original 158 CR-Kp isolates, 91.77% (145\/158) had at least one clinically relevant aminoglycoside-resistance gene. As a group, 99.37%, 84.81%, 82.28% and 10.76% of the CR-Kp isolates were susceptible to plazomicin, amikacin, gentamicin and tobramycin, respectively. The first two principal components explained 72.23% of the total variance in aminoglycoside MICs and separated isolates into four groups with aac(6\u2032)-Ib, aac(6\u2032)-Ib\u2032, aac(6\u2032)-Ib+aac(6\u2032)-Ib\u2032 or no clinically relevant aminoglycoside-resistance genes. Regression models predicted aminoglycoside MICs with adjusted R2 values of 56%\u201399%. Within the validation cohort, the categorical agreement when comparing the observed BMD MICs with the predicated MICs was 96.55%, 89.66%, 86.21% and 82.76% for plazomicin, gentamicin, amikacin and tobramycin, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Susceptibility to each aminoglycoside varies in CR-Kp. Detection of aminoglycoside-resistance genes may be useful to predict aminoglycoside MICs for CR-Kp.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkab381","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T07:37:35Z","timestamp":1633592255000},"page":"356-363","source":"Crossref","is-referenced-by-count":33,"title":["Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant <i>Klebsiella pneumoniae<\/i>"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2316-6727","authenticated-orcid":false,"given":"Yanqin","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha P.","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-8400","authenticated-orcid":false,"given":"Eric","family":"Wenzler","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-3691","authenticated-orcid":false,"given":"Egon A.","family":"Ozer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Krapp","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen B.","family":"Bulitta","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Hauser","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-911X","authenticated-orcid":false,"given":"Zackery P.","family":"Bulman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"2022050618342485800_dkab381-B1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215 Suppl 1","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"2022050618342485800_dkab381-B2","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1128\/AAC.00126-09","article-title":"Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258","volume":"53","author":"Kitchel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B3","first-page":"3346","article-title":"Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms","volume":"73","author":"Castanheira","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2022050618342485800_dkab381-B4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40265-019-1054-3","article-title":"Plazomicin: a novel aminoglycoside for the treatment of resistant Gram-negative bacterial infections","volume":"79","author":"Eljaaly","year":"2019","journal-title":"Drugs"},{"key":"2022050618342485800_dkab381-B5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/21505594.2016.1255381","article-title":"Screening for carbapenem-resistant Enterobacteriaceae: who, when, and how?","volume":"8","author":"Richter","year":"2017","journal-title":"Virulence"},{"key":"2022050618342485800_dkab381-B6","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.04292-14","article-title":"Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing","volume":"59","author":"Mathers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/mr.57.1.138-163.1993","article-title":"Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes","volume":"57","author":"Shaw","year":"1993","journal-title":"Microbiol Rev"},{"key":"2022050618342485800_dkab381-B8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: the emergence of acquired 16S Ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2022050618342485800_dkab381-B9","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/AAC.00869-16","article-title":"Association between the presence of aminoglycoside-modifying enzymes and in vitro activity of gentamicin, tobramycin, amikacin, and plazomicin against Klebsiella pneumoniae carbapenemase- and extended-spectrum-\u03b2-lactamase-producing Enterobacter species","volume":"60","author":"Haidar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B10","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/AAC.03831-14","article-title":"KPC-producing Klebsiella pneumoniae strains that harbor AAC(6\u2032)-Ib exhibit intermediate resistance to amikacin","volume":"58","author":"Bremmer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B11","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2022050618342485800_dkab381-B12","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/AAC.02638-15","article-title":"Aminoglycosides for treatment of bacteremia due to carbapenem-resistant Klebsiella pneumoniae","volume":"60","author":"Shields","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/molecules23020284","article-title":"Overcoming aminoglycoside enzymatic resistance: design of novel antibiotics and inhibitors","volume":"23","author":"Z\u00e1rate","year":"2018","journal-title":"Molecules"},{"key":"2022050618342485800_dkab381-B14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/mdr.2012.0125","article-title":"Characterization of aminoglycoside-modifying enzymes in Enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion","volume":"19","author":"Miro","year":"2013","journal-title":"Microb Drug Resist"},{"key":"2022050618342485800_dkab381-B15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fmicb.2013.00121","article-title":"Rise and dissemination of aminoglycoside resistance: the aac(6\u2032)-Ib paradigm","volume":"4","author":"Ramirez","year":"2013","journal-title":"Front Microbiol"},{"key":"2022050618342485800_dkab381-B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijantimicag.2013.03.003","article-title":"Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae","volume":"42","author":"Ginn","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2022050618342485800_dkab381-B17","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1128\/AAC.00099-14","article-title":"Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents","volume":"58","author":"Almaghrabi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B18","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/jac\/dkt180","article-title":"Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data","volume":"68","author":"Stoesser","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2022050618342485800_dkab381-B19","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3389\/fmicb.2016.01887","article-title":"Evaluation of machine learning and rules-based approaches for predicting antimicrobial resistance profiles in Gram-negative bacilli from whole genome sequence data","volume":"7","author":"Pesesky","year":"2016","journal-title":"Front Microbiol"},{"key":"2022050618342485800_dkab381-B20","doi-asserted-by":"crossref","first-page":"e00194-21","DOI":"10.1128\/mSystems.00194-21","article-title":"Genomic features associated with the degree of phenotypic resistance to carbapenems in carbapenem-resistant Klebsiella pneumoniae","volume":"6","author":"Bulman","year":"2021","journal-title":"mSystems"},{"key":"2022050618342485800_dkab381-B21","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/bioinformatics\/btv271","article-title":"kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome","volume":"31","author":"Gardner","year":"2015","journal-title":"Bioinformatics"},{"key":"2022050618342485800_dkab381-B22","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2022050618342485800_dkab381-B23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1099\/mic.0.26213-0","article-title":"Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli","volume":"149","author":"Li","year":"2003","journal-title":"Microbiology (Reading)"},{"key":"2022050618342485800_dkab381-B24","author":"CLSI","year":"2012"},{"key":"2022050618342485800_dkab381-B25","author":"CLSI","year":"2019"},{"key":"2022050618342485800_dkab381-B26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/9780470149676.ch3","volume-title":"Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery","author":"Shakya","year":"2007"},{"key":"2022050618342485800_dkab381-B27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"2022050618342485800_dkab381-B28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/cid\/cix727","article-title":"A healthcare improvement intervention combining nucleic acid microarray testing with direct physician response for management of Staphylococcus aureus bacteremia","volume":"66","author":"Eby","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2022050618342485800_dkab381-B29","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/JCM.00376-16","article-title":"Clinical impact of laboratory implementation of Verigene BC-GN microarray-based assay for detection of Gram-negative bacteria in positive blood cultures","volume":"54","author":"Walker","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2022050618342485800_dkab381-B30","doi-asserted-by":"crossref","first-page":"e0069221","DOI":"10.1128\/AAC.00692-21","article-title":"Generating genotype-specific aminoglycoside combinations with ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae","volume":"65","author":"Huang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B31","doi-asserted-by":"crossref","first-page":"e43012","DOI":"10.1371\/journal.pone.0043012","article-title":"ESSENTIALS: software for rapid analysis of high throughput transposon insertion sequencing data","volume":"7","author":"Zomer","year":"2012","journal-title":"PLoS One"},{"key":"2022050618342485800_dkab381-B32","doi-asserted-by":"crossref","first-page":"e00533-20","DOI":"10.1128\/AAC.00533-20","article-title":"Unraveling the gentamicin drug product complexity reveals variation in microbiological activities and nephrotoxicity","volume":"64","author":"Bulman","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat Med"},{"key":"2022050618342485800_dkab381-B34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/AAC.05074-11","article-title":"Changes in ciprofloxacin resistance levels in Enterobacter aerogenes isolates associated with variable expression of the aac(6\u2032)-Ib-cr gene","volume":"56","author":"Ruiz","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.20.3.344","article-title":"Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli","volume":"20","author":"Bongaerts","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/AAC.29.2.216","article-title":"High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake","volume":"29","author":"Perlin","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B37","first-page":"297","article-title":"A spontaneous point mutation in the aac(6\u2032)-Ib\u2032 gene results in altered substrate specificity of aminoglycoside 6\u2032-N-acetyltransferase of a Pseudomonas fluorescens strain","volume":"115","author":"Lambert","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"2022050618342485800_dkab381-B38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.47.2.697-703.2003","article-title":"Salmonella enterica serovar Typhimurium blaPER-1-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6\u2032-N-acetyltransferase of type Ib","volume":"47","author":"Casin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022050618342485800_dkab381-B39","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/jb.174.10.3196-3203.1992","article-title":"Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6\u2032-N-acetyltransferase Ib and IIa proteins","volume":"174","author":"Rather","year":"1992","journal-title":"J Bacteriol"},{"key":"2022050618342485800_dkab381-B40","doi-asserted-by":"crossref","first-page":"e01934-17","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI Methods Development and Standardization Working Group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2022050618342485800_dkab381-B41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jac\/dkaa480","article-title":"Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6\u2032)-Ib","volume":"76","author":"Butler","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2022050618342485800_dkab381-B42","doi-asserted-by":"crossref","first-page":"e00489-17","DOI":"10.1128\/mBio.00489-17","article-title":"Population genomic analysis of 1,777 extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates, Houston, Texas: unexpected abundance of clonal group 307","volume":"8","author":"Long","year":"2017","journal-title":"mBio"},{"key":"2022050618342485800_dkab381-B43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41598-017-18972-w","article-title":"Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae","volume":"8","author":"Nguyen","year":"2018","journal-title":"Sci Rep"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/2\/356\/43599875\/dkab381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/2\/356\/43599875\/dkab381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T18:40:31Z","timestamp":1651862431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/2\/356\/6403927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,10,20]]},"published-print":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab381","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,10,20]]}}}